Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC
Clinical trial NCT02330367 · UNKNOWN
Trial details
- NCT number
- NCT02330367
- Sponsor
- Hangzhou ACEA Pharmaceutical Research Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2022-12-01
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.